Yazen combines medication treatment with digital medical guidance and lifestyle interventions. The company positions itself as an alternative to traditional obesity care, in a healthcare system that is under pressure due to staff shortages and a growing demand for care.
'We see a lot of demand in the Netherlands for structured, measurable guidance,' says Nicole Diebels, country manager of Yazen Netherlands. 'The current system is only limitedly set up for that. Digital care makes it possible to continuously monitor patients and make timely adjustments, instead of treating reactively.'
Also read: Dawn Technology strengthens Digital Platforms with the arrival of Wolf Marcuse
Revenue increase
Yazen has more than 37,000 active patients and is now active in seven European countries. In 2025, Yazen's international total revenue increased by 87 percent to nearly 29.4 million euros, according to the annual figures. The gross profit doubled to approximately 16.5 million euros. Further expansion into two new markets is planned for 2026. Yazen has 290 employees, including 130 doctors.
Also read: Smart security: endpoint security as a basis at HP
In 2025, Yazen was named Weight Loss Treatment of the Year in Europe by the trade magazine Healthcare Business Review. The technology platform Sifted ranked the company second in its list of fast-growing European startups.
Also read: AI in marketing: where do you apply it?
